Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines

Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines

Head and neck cancers (HNSCCs), especially in the advanced stages, are predominantly treated by radiochemotherapy, including cisplatin. The cure rates are clearly higher for HPV-positive HNSCCs when compared to HPV-negative HNSCCs. For both entities, this treatment is accompanied by serious adverse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Autoren: Subtil, Florentine S. B., Gröbner, Carolin, Recknagel, Niklas, Parplys, Ann Christin, Kohl, Sibylla, Arenz, Andrea, Eberle, Fabian, Dikomey, Ekkehard, Engenhart-Cabillic, Rita, Schötz, Ulrike
Format: Artikel
Sprache:Englisch
Veröffentlicht: Philipps-Universität Marburg 2023
Schlagworte:
Medizin
HPV
NVP-BEZ235
clonogenic survival
cisplatin
HNSCC
radiosensitization
irradiation
Medical sciences Medicine
Online-Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

PDF-Volltext

Bestandsangaben von
Signatur: urn:nbn:de:hebis:04-es2023-00333
Publikationsdatum: 2023-04-03
Quelle: Erstveröffentlichung: Subtil, F.S.B.; Gröbner, C.; Recknagel, N.; Parplys, A.C.; Kohl, S.; Arenz, A.; Eberle, F.; Dikomey, E.; Engenhart-Cabillic, R.; Schötz, U. Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines. Cancers 2022, 14, 3160. https://doi.org/10.3390/cancers14133160
Downloads: 43 (2024), 73 (2023)
Lizenz: https://creativecommons.org/licenses/by/4.0
Zugangs-URL: https://archiv.ub.uni-marburg.de/es/2023/0033
https://doi.org/10.3390/cancers14133160

Ähnliche Einträge